MS Speaks

Multiple Sclerosis => MS - RESEARCH AND NEWS => Topic started by: agate on March 07, 2018, 03:58:01 pm

Title: Study uncovers potential risks of beta interferon treatment (Avonex, Betaseron, Rebif, Extavia)
Post by: agate on March 07, 2018, 03:58:01 pm
From MS Focus, a publication of the MS Foundation. The article concerns a study in the journal Neurology about possible risks of the beta interferon drugs in the treatment of MS:


https://msfocus.org/About-Us/MSF-News-Articles/54


The Neurology article (June 13, 2017)--"Evaluating the safety of beta-interferons in MS"--is available:


http://n.neurology.org/content/88/24/2310